![Li Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 27 M $ as of 31/05/2026
Li Wang is the founder of Shanghai AngioCare Medical Technology Co., Ltd. since 2011, holding the title of Director.
Mr. Wang is the founder of Shanghai Bio-Heart Biological Technology Co., Ltd. since 2014, holding the title of Chairman & Chief Executive Officer.
Former positions include Marketing Director at Medtronic, Inc., Marketing Director at Boston Scientific Corp., Director at Shanghai Kinetic Medical Co., Ltd. from 2013 to 2019, Executive Director & Manager at Essen Technology (Beijing) Co., Ltd. from 2013 to 2020, Manager at Guidant Corp., and Chief Operating & Marketing Officer at MicroPort Scientific Corp.
from 2002 to 2012.
Education includes undergraduate studies at the University of California, Berkeley, undergraduate degree conferred in 1993 from the University of California, Davis, and an MBA conferred in 1996 from the University of California, Davis.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/06/2026 | 62,356,294 ( 26.46% ) | 24 M $ | 31/05/2026 | |
| 30/06/2025 | 7,713,678 ( 3.27% ) | 3 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD. | Chief Executive Officer | 18/07/2014 |
Shanghai AngioCare Medical Technology Co., Ltd.
 Shanghai AngioCare Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Manufactures medical instruments and device | Founder | 01/09/2011 |
| Companies | Position | End |
|---|---|---|
Essen Technology (Beijing) Co., Ltd.
 Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Manufactures medical stents | Chairman | 01/12/2020 |
| SHANGHAI KINETIC MEDICAL CO., LTD | Director/Board Member | 01/04/2019 |
| MICROPORT SCIENTIFIC CORPORATION | Chief Executive Officer | 01/01/2012 |
| BOSTON SCIENTIFIC CORPORATION | Sales & Marketing | - |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Sales & Marketing | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MicroPort Scientific Corp.
 MicroPort Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical products | Health Technology |
Shanghai Kinetic Medical Co., Ltd.
 Shanghai Kinetic Medical Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Health Technology |
Essen Technology (Beijing) Co., Ltd.
Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Manufactures medical stents | Health Technology |
Shanghai AngioCare Medical Technology Co., Ltd.
Shanghai AngioCare Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Manufactures medical instruments and device | Health Technology |
Shanghai Bio-Heart Biological Technology Co., Ltd.
 Shanghai Bio-Heart Biological Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops drug eluting bioresorbable coronary stent systems | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
